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Introduction: Nitric oxide (NO) is an intracellular and intercellular messenger that plays an important
role in cellular events in physiological and pathophysiological processes. NO is one of the inﬂammation
markers and macrophages of an inﬂammatory cell produce a large amount of NO compared with other
cells. Non-invasive detection system of NO is highly required to realize an early therapeutic treatment
considering the process of pathophysiological changes. The objective of this study is to develop an im-
aging agent of nitric oxide (NO).
Methods: A water-insoluble DAR-4M of ﬂuorescent dye for NO was solubilized in water through the
micelle formationwith gelatin grafted with L-a-phosphatidylethanolamine distearoyl (DAR-4Mmicelles).
Physicochemical and biological properties of DAR-4M micelles were investigated by using cultured cells
and animals.
Results: The DAR-4M micelles responded to NO secreted from a NO donors, in contrast to the same
concentration of free DAR-4M. When RAW264.7 of a macrophage cell line was stimulated by lipopoly-
saccharide (LPS) to allow them to generate NO, the DAR-4M micelles could detect NO of the cells to a
signiﬁcant great extent compared with free DAR-4M. After the intravenous injection of DAR-4M micelles
or free DAR-4M to a mouse model of aristolochic acid (AA) induced acute interstitial nephritis, the DAR-
4M micelles enhanced the ﬂuorescence intensity from the kidneys to a signiﬁcant great extent compared
with the free DAR-4M injection. In case of DAR-4M micelles injection into normal mice, such an
enhanced kidney ﬂuorescence was not observed. A body distribution experiment demonstrated that the
kidney accumulation of DAR-4M micelles was not modiﬁed by the AA-induced inﬂammation. After the
AA injection, the number of CD11b-positive cells increased with time, indicating the increased number of
inﬂammatory macrophages.
Conclusion: DAR-4M micelles are effective in imaging NO generated from macrophages accompanied
with inﬂammation.
© 2016, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Inﬂammation is one of the biological responses to various
exogenous and endogenous stimuli which cause the cellular and
tissue injuries. Recently, it has been demonstrated that the
inﬂammation and regeneration are strongly related to each other
[1]. For example, the regeneration is not occurred withouts, Field of Tissue Engineering,
sity, 53 Kawara-cho Shogoin,
46.
. Tabata).
se Society for Regenerative
ative Medicine. Production and hoinﬂammation. The extent and duration of inﬂammation reaction
affect the subsequent regeneration process. In this context, it is no
doubt that the inﬂammation imaging contributes to the develop-
ment of efﬁcient regenerative therapy. Macrophages are one of
immune cells which play a critical role in inﬂammation responses
by modulating the biological functions [2]. Therefore, it is impor-
tant to develop the materials and technologies to control and
visualize the biological functions of macrophages.
Nitric oxide (NO) is an intracellular and intercellular messenger
that plays an important role in cellular events in physiological and
pathophysiological processes [3e6]. NO acts as a vascular relaxing
agent, a neurotransmitter, and an inhibitor of platelet aggregation.
In addition, it is recognized that NO is generated during immune
and inﬂammatory responses [7]. It functions in innate immunity assting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
Abbreviations
NO nitric oxide
nNOS neuronal NOS
eNOS endothelial NOS
DSPE L-a-phosphatidylethanolamine distearoyl
DSPE-NHS N-(Succinimidyloxy-glutaryl)-DSPE
LPS lipopolysaccharide
SNP nitroprusside
EtOH ethanol
aDMSO anhydrous dimethyl sulfoxide
DDW double-distilled water
DMEM Dulbecco's Modiﬁed Eagle Medium
FCS fetal calf serum
WST-8 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-
(2,4-disulfophenyl) -2H- etrazolium
AA aristolochic acid
HBSS Hank's balanced salt solution
7-AAD 7-Amino-Actinomycin D
CMC critical micellar concentration
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regulate death and function of host immune cells. Nitric oxide
synthase (NOS) of enzyme to generate NO has been extensively
investigated [8e10]. NO is generally biosynthesized by three iso-
forms of mammalian NOS [11]. Neuronal NOS (nNOS or NOS I) and
endothelial NOS (eNOS or NOS III) are constitutively expressed in
neuronal and endothelial cells, respectively. Both are also referred
to as cNOS. Inducible NOS (iNOS or NOS II) is expressed in cells
involved in inﬂammation, such as macrophages and microglias
when stimulated by cytokines and/or endotoxins. Generally, the
level of NO produced by cNOS in stimulated endothelial and
neuronal cells is much lower (nanomolar [nM] range) than that
generated by iNOS in macrophages (micromolar [mM] range). It is
recognized that an excessive production of NO is believed to be
responsible for various pathophysiologies, but very low levels of NO
are needed to maintain normal physiological conditions. The NO
production is closely associated with the expression of NOS [12].
Among several NO detecting dyes developed [13e17], DAR-4M
is one of ﬂuorescence dyes and has been used as the NO detect-
ing agents in both in vitro and in vivo systems. Since the DAR-4M
emits the ﬂuorescence only in the presence of NO, the NO detec-
tion with a high signal-to-noise ratio is realized [13]. However,
there are issues to be improved for the in vivo use. The DAR-4M is a
small and water-insoluble molecule which is easily diffused and
disappear in the body. Thus, it is practically difﬁcult to maintain
high concentrations at the site of NO to be detected. Several re-
searches have been reported to improve the imaging efﬁciency of
dyes by making use of materials sciences [18e21].
Gelatin is a biodegradable material and has been extensively
used for food, pharmaceutical, and medical purposes. The biosafety
has been proven through their long practical applications. Gelatin is
a denatured form of collagen which is the most abundant compo-
nent of extracellular matrix in the body tissue. The material itself
and the product degraded are both biocompatible. It is also reported
that the gelatin pre-coating of microspheres augments the phago-
cytosis of macrophages [22]. Hydrophobic derivatives of gelatins are
effective in water-solubilization of water-insoluble and low-
molecular weights drugs and enhancing their biological activity [23].
This study is undertaken to design the water-soluble micelles of
DAR-4M for improved NO detection. The DAR-4M was solubilized
in water by the micelle formation with a derivative of gelatingrafted with L-a-phosphatidylethanolamine distearoyl (DSPE)
(DAR-4M micelles). The ability of DAR-4M micelles to image NO
was evaluated by the in vitro cell culture with macrophages and an
inﬂammation model at mice in vivo. We compare the NO imaging
ability with that of free DAR-4M.
2. Materials and methods
2.1. Materials
Gelatin with an isoelectric point (pI) of 5.0 (weight-average
molecular weight (Mw)¼ 10,000), prepared via an alkaline process
of bovine bone (pI5 gelatin) was kindly supplied from Nitta Gelatin
Co., Osaka, Japan. N-(Succinimidyloxy-glutaryl)-L-a-phosphatidyl-
ethanolamine, distearoyl (DSPE-NHS) was purchased from NOF Co.,
Tokyo, Japan. Diaminorhodamine-4M (DAR-4M) was purchased
from Sekisui Medical Co., Ltd., Tokyo, Japan. Collagenase D was
purchased from Roche diagnosis Inc., and used in the in vivo study
because of its lower cytotoxicity compared with collagenase L.
Lipopolysaccharide (LPS), nitroprusside (SNP) as a NO donor, and
other chemicals were purchased from Wako Pure Chemical in-
dustries, Ltd., Osaka, Japan.
2.2. Synthesis of gelatin grafted with DSPE
PI5 gelatin with Mw of 10,000 (1.0 g) was dissolved in anhy-
drous dimethyl sulfoxide (aDMSO) at room temperature. DSPE-NHS
(1.0 g) was dissolved in aDMSO at room temperature. Next, the
gelatin solution in aDMSO was slowly added to the DSPE-NHS so-
lution in aDMSO to give the DSPE/gelatin molar ratios of 1, 3, 5, and
10, and then stirred overnight at room temperature to allow DSPE
to graft to gelatin. The resulting solution was dialyzed by double-
distilled water (DDW) similarly for 72 h at room temperature,
and freeze-dried to obtain DSPE-grafted gelatin samples (DSPE-g-
gelatin). The extent of DSPE grafted to gelatin and the critical
micellar concentration (CMC) of DSPE-g-gelatin were determined
by the conventional molybdenum blue method to measure the
phosphorus amount [24] and the ﬂuorescence quenching of pyrene
in DSPE-g-gelatin [25], respectively.
2.3. Water-solubilization of DAR-4M by DSPE-g-gelatin
DAR-4M solution (2.1 mg/ml) in aDMSO (4.0 ml) was added to
5 ml of DSPE-g-gelatin aDMSO solution (4.0 mg/ml), followed by
1 h stirring at room temperature. Then, the mixed solution was
dialyzed with Spectra/Por®Dialysis Membrane MWCO: 3500
(Spectrum Laboratories, Inc, CA) against DDW for 72 h at room
temperature. The dialysate obtained was centrifuged (8000 rpm,
10 min, 25 C) to exclude the water-insoluble fraction, and freeze-
dried to obtain the DAR-4M water-solubilized by DSPE-g-gelatin
micelles (DAR-4Memicelles). The size of DAR-4M micelles was
measured by a Zetasizer Nano ZS90 (Malvern Instruments Ltd.,
Malvern, UK). The amount of DAR-4M water-solubilized in each
micelle was determined by measuring the absorbance of DAR-4M
at the wavelength of 315 nm after dissolving each micelle in
aDMSO.
2.4. Evaluation of the DAR-4M micelles response to NO donors
The response of DAR-4M micelles to NO donors was evaluated
according to the conventional ﬂuorescence measurement [13].
Brieﬂy, DAR-4M micelles at the DAR-4M concentration of 10 mM
(3.14 mg/ml) were added into 10 mM phosphate-buffered saline
(PBS, pH 7.4) or SNP/PBS solution in each well of 96-well multi-well
black plate (Corning Inc., Corning, NY). The ﬂuorescent intensity of
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reader (Gemini EM Fluorescence Microplate Reader, Molecular
Devices, LLC). These samples were used for every experiment
independently unless otherwise mentioned.
2.5. Cytotoxicity test
RAW 264.7 cells of a macrophage cell line were seeded on each
well of 24 well multi-dish culture plate (Corning Inc., Corning, NY)
at a density of 1 104 cells/cm2 and cultured in 500 ml of Dulbecco's
Modiﬁed Eagle Medium (DMEM) (Invitrogen Corporation, Ltd.,
Carlsbad, CA) with 10 vol% fetal calf serum (FCS) for 24 h. Next, the
medium was exchanged to DMEM, and then the DAR-4M micelles
and free DAR-4M in DMEM were added to each well. After 3 h in-
cubation, the number of cells proliferated was evaluated with a 2-
(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-
disulfophenyl) -2H-tetrazolium (WST-8) assay kit (Nacalai Tesque.
Inc., Kyoto, Japan).
2.6. Evaluation of DAR-4M micelles response to RAW 264.7 cells
RAW264.7 cells were seeded on glass bottom dish (Matsunami
Glass Ind.,Ltd., Osaka, Japan) at a density of 1  105 cells/cm2 and
cultured in 1 ml of DMEM medium with 10 vol% FCS for 24 h. The
mediumwas exchanged to DMEM containing 100 ng/ml of LPS, and
incubated further for 24 h. Next, the medium was exchanged to
FCS-free DMEM, and then, free DAR-4M, DSPE-g-gelatin, the
mixture of free DAR-4M and DSPE-g-gelatin, or DAR-4M micelles
were added to each dish. After 1 h incubation, cells were washed
with PBS. The cells were viewed on a Nikon ECLIPSE 90i confocal
laser scanning microscope (Nikon Corp., Tokyo, Japan).
To evaluate the ﬂuorescent intensity of cells incubated for 1 h
with free DAR-4M, DSPE-g-gelatin, the mixture of free DAR-4M and
DSPE-g-gelatin, and DAR-4Mmicelles, RAW264.7 cells were seeded
on each well of 24 well multi-dish culture plate (Corning Inc.,
Corning, NY) at a density of 1  105 cells/cm2 cultured in 1 ml of
DMEMwith 10 vol% FCS for 24 h. Then, the mediumwas exchanged
to FCS-free DMEM, and free DAR-4M, DSPE-g-gelatin, the mixture
of free DAR-4M and DSPE-g-gelatin or DAR-4M micelles were
added to each well. After 1 h incubation, cells were washed with
PBS. The cells were viewed on a Nikon ECLIPSE 90i confocal laser
scanning microscope (Nikon Corp., Tokyo, Japan).
2.7. Observation of DAR-4Mmicelles localization in RAW 264.7 cells
The intracellular localization of DAR-4M micelles was detected
using LysoTracker Green DND-26 (Life Technologies Japan.,Ltd.,
Tokyo, Japan) according to the product manual. Brieﬂy,
RAW264.7 cells were seeded on glass bottom dish (Matsunami
Glass Ind.,Ltd., Osaka, Japan) at a density of 1  105 cells/cm2 and
cultured in 1 ml of DMEM medium with 10 vol% FCS for 24 h. The
mediumwas exchanged to DMEM containing 100 ng/ml of LPS, and
incubated further for 24 h. Next, the medium was exchanged to
FCS-free DMEM containing 75 nM of LysoTracker Green DND-26,
and then, DAR-4M micelles were added to each dish. After 1 h in-
cubation, cells were washed with PBS. The cells were viewed on a
Nikon ECLIPSE 90i confocal laser scanning microscope (Nikon
Corp., Tokyo, Japan).
2.8. Animal experiments with a model of aristlochic acid-induced
kidney inﬂammation model
A mouse model of aristolochic acid (AA) induced interstitial
nephritis was prepared as the inﬂammation animal [26]. All the
animal experimentation was conducted in accordance with theGuidance of the Institute for Frontier Medical Sciences, Kyoto
University. After 1 week of acclimatization, mice were intraperi-
toneally injected with AA solution in saline (5 mg/kg body weight)
(AA group) or with the saline alone (original group). Imaging assay
was performed 1, 4, 7, 14, 21, and 35 days after AA treatment. In vivo
ﬂuorescence images was performed by IVIS Spectrum (PerkinElmer
Inc., Waltham, MA) at the excitation and emission wavelengths of
535 and 580 nm, respectively. DAR-4Mmicelles (3.14 mg/ml, 10 mM
of DAR-4M, 200 ml) and free DAR-4M (10 mM of DAR-4M, 200 ul)
were injected into the tail vein of mice (2 nmole DAR-4M/mice) at
the days indicated above. Mice were sacriﬁced 1 h later, and the
kidneyswere isolated, followed by the ﬂuorescence imaging on IVIS
Spectrum. To determine the ﬂuorescence intensity of the AA-
treated and normal kidneys, the kidneys isolated was assessed by
the IVIS Spectrum.
2.9. Flow cytometry of kidney cells
To quantitatively analyze the type of inﬂammatory cells inﬁl-
trated into the AA kidney, kidneys were enzymatically digested to
prepare the cell suspensions [27], followed by the analysis of ﬂow
cytometry (FACSCanto II ﬂow cytometer BD Biosciences, Co., Tokyo,
Japan). Brieﬂy, kidneys were dissected, placed in Hank's Balanced
Salt Solution (HBSS) containing 1.6 mg/ml collagenase D for
30 min at 37 C, and then washed twice in HBSS. Following the
erythrocyte lysis with lysis buffer (BD Pharm Lyse, BD Biosciences
Ltd., Rockville, MD), cells were resuspended in PBS containing 2 vol
% FBS and 0.1 vol% sodium azide (FACS buffer). The kidney cells
suspension was blocked by anti-CD16/32 antibody (BioLegend Ltd.,
San Diego, CA), washed, and stained with an anti-CD11b antibody
(BioLegend Ltd., San Diego, CA), an anti-CD 45 antibody against
CD45 expressed on the surface of mouse macrophages (BioLegend
Ltd., San Diego, CA) in FACS buffer. 7-Amino-Actinomycin D (7-AAD,
BD Biosciences Ltd., Rockville, MD) was used to distinguish dead
cells from viable cells. The immunostained cells were analyzed on
FACS, and the analysis was performed by the BD FACSDiva software
(v6.13 BD FACSDiva software, BD Biosciences Ltd., Rockville, MD).
2.10. Evaluation of body distribution
The body distribution of DAR-4M micelles was evaluated by use
of 125I-labeled DAR-4M micelles. Brieﬂy, DAR-4M micelles were
labeled with 125I according to the method reported previously [28].
The 125I-labeled DAR-4M micelles were intravenously injected into
mice 1, 4, 7, 21, and 35 days after AA treatment. The mice were
sacriﬁced 1 h after injection of 125I-labeled DAR-4M micelles, and
the tissues and organs were excised. Then, the radioactivity of tis-
sues and organs was counted by a gamma counter (Auto Well
Gamma System ARC-380 CL, Aloka Co., Ltd, Tokyo, Japan). The
percentage of radioactivity was expressed as 100% for the radio-
activity of antibody initially injected.
2.11. Statistical analysis
Data were expressed as the means± standard deviations. They
were analyzed using TukeyeKramer paired comparison test, while
the signiﬁcance was accepted at p < 0.05.
3. Results
3.1. Characterization of gelatin derivatives and DAR-4M micelles
Table 1 shows the preparation conditions and characterization
of DSPE-g-gelatin and DAR-4Mmicelles. The amount of DSPE added
was in a good accordance with the percentage of DSPE introduced.
Table 1
Physicochemical properties of DSPE-g-gelatin and DAR-4M micelles.
Sample code DSPE-g-gelatin DAR-4M micelles
DSPE-NHS
added (mole/mole gelatin)
Percentage of DSPE
grafted (mole/mole gelatin)
Critical micellar
concentration (mg/ml)
Amount of DAR-4M
water-solubilized (mmole/mole gelatin)
Size (nm)
DSPE-1 1 18.5 ± 1.8a 11.4 ± 0.2a 21.8 ± 4.9a 30.4 ± 9.1a
DSPE-3 3 46.6 ± 3.6 9.4 ± 0.2 42.4 ± 5.0 80.8 ± 32
DSPE-5 5 75.2 ± 2.5 4.7 ± 0.1 48.5 ± 5.2 124 ± 44
DSPE-10 10 100 ± 4.1 3.3 ± 0.1 65.2 ± 5.3 105 ± 35
a Mean ± SD.
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amount of DSPE introduced increased. The amount of DAR-4M
introduced into the DSPE-g-gelatin micelles became larger with
an increase in the amount of DSPE introduced. The diameter of
DAR-4M micelles ranged from 30 nm to 125 nm. The DAR-4M
micelles prepared from the DSPE-10 gelatin showed the largest
amount of DAR-4M incorporated, while the diameter was around
100 nm. Based on this, the DAR-4M micelles of DSPE-10 were used
for the following experiments.
3.2. NO reactivity of DAR-4M micelles
Fig. 1 shows the effect of DAR-4M concentration on the reac-
tivity of free DAR-4M or DAR-4Mmicelles to NO produced from NO
donors. Irrespective of the DAR-4M concentration, free DAR-4M
responded to the NO donor. On the other hand, DAR-4M micelles
weakly responded to SNP at any concentration.
3.3. In vitro evaluation of DAR-4M micelles imaging ability
Fig. 2 shows the cytotoxicity of DAR-4M micelles. The DAR-4M
micelles at concentrations less than 5 mM did not have any signif-
icant cytotoxicity.
Fig. 3 shows the confocal laser microscopic pictures of RAW
264.7 cells. For free DAR-4M, LPS-stimulated RAW264.7 cells pro-
duced NO and the production was detected (A and E). When DSPE-
g-gelatin alonewere added to cells with or without LPS stimulation,
no ﬂuorescence was observed for both the groups (B and F). For the
mixture of DSPE-g-gelatin micelles and free DAR-4M, ﬂuorescence
was observed only for the cells with LPS stimulation (C and G).
When DAR-4M micelles were added to cells with or without LPSFig. 1. Effect of DAR-4M concentration on the reactivity of DAR-4M micelles (-) or
free DAR-4M (▫) to NO donors. The DAR-4M micelles were prepared by DSPE-10. The
ﬂuorescent intensity ratio was calculated as the ﬂuorescence intensity of 1.0 for the
group in NO-donor-free PBS at the corresponding DAR-4M concentration. *p < 0.05;
signiﬁcance between the two groups.stimulation, ﬂuorescence was observed only for LPS-stimulated
cells, but not for cells without LPS stimulation (D and H).
Fig. 4 shows the ﬂuorescent intensity of LPS stimulated
RAW264.7 cells incubated with free DAR-4M, DSPE grafted-gelatin
micelle with free DAR-4M, or DAR-4Mmicelle. For every group, the
higher ﬂuorescent intensity was observed at higher concentrations
of DAR-4M added. At the same concentration of DAR-4M, signiﬁ-
cantly stronger ﬂuorescence was detected for the DAR-4M micelles
groups.
Fig. 5 shows the confocal laser microscopic picture of RAW
264.7 cells incubated with LysoTracker Green DND-26 and DAR-4M
micelles. The ﬂuorescence of DAR-4M micelles themselves merged
with that of DND-26. The DAR-4M micelles were localized in the
phagolysosome of cells.3.4. In vivo evaluation of DAR-4M micelles imaging ability
Fig. 6 shows the IVIS images of isolated kidneys of mice 1 h after
intravenous injection of free DAR-4M and DAR-4M micelles. Mice
were treated with AA for 1, 4, 7, 21, and 35 days. When free DAR-4M
was injected into mice, there was not a big difference in the ﬂuo-
rescent intensity between the inﬂamed and normal kidneys. On the
contrary, for the DAR-4M micelles injection, there was signiﬁcant
difference in the ﬂuorescent intensity between the two kidneys.
Moreover, the ﬂuorescence intensity of isolated kidney increased
with time after AA treatment. The ﬂuorescence intensity was
higher for the DAR-4M-micelles group than for the free DAR-4M
group. Fig. 7 shows percentage of CD11b-positive cells to the total
live cells in the kidneys. The percentage of CD11b-positive cells in
kidney inﬂamed increased with time.Fig. 2. Effect of the DAR-4M micelles concentration on the viability of RAW264.7 cells
3 h after incubation. The DAR-4Mmicelles were prepared at DAR-4M concentrations of
0.5, 1, 2, 5, 10, and 20 mM. The viability of cells cultured without DAR-4M micelles
(DAR-4M concentration ¼ 0) is indicated as 100%. *, p < 0.05; signiﬁcant against the
viability of cells cultured without DAR-4M micelles.
Fig. 3. Confocal laser microscopic pictures of RAW264.7 cells 1 h after incubation with (A, E) free DAR-4M, (B, F) DSPE-10, (C, G) the mixture of free DAR-4M and DSPE-10, and (D, H)
DAR-4M micelles. Cells were stimulated for 24 h by 100 ng/mL of LPS (A, B, C, D) and not (E, F, G, H). The DAR-4M micelles were prepared by DSPE-10. Scale bar is 50 mm.
Fig. 4. Fluorescent intensity of LPS-stimulated cells 1 h after incubation with free DAR-
4M (-), the mixture of free DAR-4m and DSPE-10 (▫), and DAR-4M micelles ( ). The
LPS concentration is 100 ng/ml. The DAR-4M micelles were prepared by DSPE-10. *p <
0.05; signiﬁcance between the two groups.
Fig. 5. Confocal laser microscopic pictures of cells 1 h after incubation with DAR-4M
micelles. Red: DAR-4M. Green: lysosome. Scale bar is 50 mm.
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125I-labeled DAR-4M micelles. Little difference in the proﬁle of
kidney accumulation was observed at different time intervals after
AA treatment.
4. Discussion
The present study demonstrates that DAR-4M incorporated into
the micelles of DSPE-g-gelatin micelles could detect NO effectively
in both the in vitro and in vivo systems. NO could be detected at the
DAR-4M concentration of 5 mM, where no signiﬁcant cytotoxicity
was seen (Fig. 2). The DAR-4M of a water-insoluble drug was sol-
ubilized in water by making use of the gelatin micelles. Several
researches have been reported on the water-solubilization and
cellular internalization of hydrophobic ﬂuorescent dyes with
different types of polymer micelles [29e32]. In this study, gelatin
was selected as a starting material of polymer micelles for the
following reasons. First, it has been recognized that the particles
composed of or coated with gelatin are susceptible to the inter-
nalization by macrophages [22,33]. In addition, drugs encapsulated
in gelatin particles can be released in the cells after their inter-
nalization [33,34].
In this study, the DSPE-10 was selected as the gelatin derivative
to form DAR-4Mmicelles. This is because the micelles incorporated
showed the highest amount of DAR-4M. In addition, the diameter of
DAR-4Mmicelles was about 105 nm (Table 1). It is reported that the
nanoparticles with sizes of 50e200 nm can be penetrated through
the vascular walls of inﬂamed tissues and accumulated into
inﬂamed tissue. This is called enhanced permeability and retention
(EPR) effect [35,36]. Based on the points, the DAR-4M micelles of
DSPE-10 gelatin derivatives was used to detect NO production in
the inﬂammation site.
Free DAR-4M responded to NO produced by the NO donor,
whereas the DAR-4M micelles hardly responded to NO (Fig. 1).
This can be due to the entrapment of DAR-4M in micelles. It is
conceivable that the DAR-4M is encapsulated into the micelles,
resulting in no DAR-4M contact with NO to detect.
It is reported that LPS stimulation enhances the NO secretion
from RAW264.7 cells [37,38]. Fluorescence was observed at the
cytosol of cells even after their PBS washing. This is because DAR-
4M itself is penetrated into the cytosol through the cellular
Fig. 6. IVIS analysis of isolated kidneys of mice 1 h after intravenous injection of free DAR-4M and DAR-4Mmicelles. Mice were treated with AA for 1, 4, 7, 21, and 35 days. The DAR-
4M micelles were prepared by DSPE-10. (A) IVIS images of isolated kidney. (B) Total photon ﬂux of isolated kidneys after intravenous injection of free DAR-4M (-) and DAR-4M
micelles (▫).
Fig. 7. Percentage of CD11b-positive cells to the total live cells in kidneys of AA-treated
mice after injection of DAR-4Mmicelles. The DAR-4Mmicelles were prepared by DSPE-
10. *p < 0.05; signiﬁcance between the two groups.
Fig. 8. Body distribution of mice 1 h after intravenous injection of 125IeDAR-4M mi-
celles. 125IeDAR-4M micelles were intravenously injected to the normal (0 day after
injection) (-) and AA-treated mice 1 day (▫), 4 days ( ), 7 days ( ), 21 days ( ) and 35
days ( ) after injection.
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M. Tatsutomi et al. / Regenerative Therapy 5 (2016) 64e7170membrane [13] (Fig. 3A and E). Fluorescence was also seen for
LPS-stimulated cells incubated with the mixture of DSPE-g-
gelatin micelles and free DAR-4M or DAR-4M micelles (Fig. 3C
and D). On the other hand, no ﬂuorescence was detected
(Fig. 3B). The ﬁndings indicate that DSPE-grafted gelatin itself
does not generate ﬂuorescence. Even at the same concentration
of DAR-4M added to cells, the DAR-4M micelles showed higher
ﬂuorescent intensity than free DAR-4M (Fig. 4). The DAR-4M
micelles were localized inside cells (Fig. 5). We can say with
certainty that the increased amount of DAR-4M in the cytosol of
cells was achieved by the phagocytosis of DAR-4M micelles. The
micelles phagocytosis would allow the DAR-4M to concentrate in
the cells.
DAR-4M micelles imaged the inﬂamed kidney to a signiﬁcantly
great extent compared with free DAR-4M (Fig. 6). The DAR-4M
incorporated into the micelles increased the amount of DAR-4M
in cells. Because the phagocytosis of micelles can carry a large
amount of DAR-4M into cells at one time compared with the simple
permeation of free DAR-4M into cells. Moreover, the micelles for-
mation would allow DAR-4M to stabilize in the body, prolong the
half-life in the blood circulation, and increase the amount of DAR-
4M in the cytosols of cells. As the result, the micelles effectively
enhanced the imaging ability of DAR-4M in vivo compared with
that of free DAR-4M in vivo. It is apparent from Fig. 7 that the
number of CD11b-positive cells increased with time after AA
treatment. This suggests that the cells were recruited into the
kidney inﬂamed, in contrast to the normal kidney. In addition, the
ﬂuorescent intensity increased with time (Fig. 6A). On the contrary,
in the normal kidney, weaker imaging was observed even for the
DAR-4M micelles injection group. Taken together, it is highly
possible that the DAR-4M micelles imaged CD11b-positive inﬂam-
mation cells like macrophages in terms of NO production.
Little difference in the body distribution of the DAR-4Mmicelles
was observed between the normal and inﬂamed kidneys (Fig. 8).
On the contrary, the ﬂuorescence intensity of kidneys was signiﬁ-
cantly different between them (Fig. 6). The ﬁndings may be
explained in terms of the micelles ability to image inﬂammation
cells. It is possible that the DAR-4M micelles localized in the in-
ﬂammatory site are effectively taken up by macrophages, resulting
in the superior imaging of inﬂammation.
It is known that although light in the visible range is routinely
used for intravital microscopy, the imaging of deeper tissues
(>500 mm to cm) requires the use of near infrared (NIR) light. In the
body, there are hemoglobin and water which work as the major
absorbers of visible and infrared light, respectively. The absorption
coefﬁcient of conventional agents is normally the lowest at the NIR
region around 650e900 nm [39e42]. The excitation and emission
wavelength of DAR-4M used in this study are 560 and 575 nm,
respectively. This is because the kidney could not be directly
imaged in live mice. Development of NO detecting agents at the
excitation and emission wavelengths of NIR region is required to
image the inﬂamed kidney in live mice.
It is recognized that there are, at least, two phenotypes of
macrophages, called as M1 and M2. M1 macrophages with classi-
cally pro-inﬂammatory functions are superior in number in in-
ﬂammatory reactions and pathogen defense [2,43,44]. On the other
hands, M2 macrophages with alternatively non-inﬂammatory
functions promote the responses of type 2 helper T cells associ-
ated with tumor progression [43], parasite infections, tissue repair
[2,44], and debris removal [44e46]. If M1 and M2 can be discrim-
inated by their imaging, it would be possible to visualize the con-
ditions of inﬂammation reactions in terms of macrophages
movement in vivo. Based on this idea, in this study, we tried to
image M1 macrophage by using NO production. NO production is
one of themarkers for M1macrophages [47]. Imagingmethodologyto visualize the in vivo movement of M1 macrophages and M2
macrophages will open a new ﬁeld of inﬂammation imaging.5. Conclusion
DAR-4M incorporated into DSPE-g-gelatin micelles could detect
NO effectively in both the in vitro and in vivo systems without
signiﬁcant cytotoxicity. The DAR-4M of a water-insoluble drug was
solubilized in water by making use of the gelatin micelles. The
incorporation into the micelles allowed DAR-4M to increase the
amount in cells. Moreover, the micelles formation could stabilize
DAR-4M in the body, prolong the half-life in the blood circulation,
and increase the amount of DAR-4M in the cytosols of cells. It is
concluded that the DAR-4M micelles have an effective imaging
ability in vivo compared with free DAR-4M.Conﬂict of interest
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